† Study has passed its completion date and status has not been verified in more than two years.
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
|2||Enrolling by invitation||
A Study to Assess the Long-term Safety of Dupilumab (REGN668/SAR231893) Administered in Patients 6 to <18 Year of Age With Atopic Dermatitis (AD)
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2%
Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream
Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.